Algo version: 0.98b
Prescient Therapeutics is listed at the ASX Exchange
Prescient Therapeutics [PTX.AX]
ASX Sector: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Is Prescient Therapeutics stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Prescient Therapeutics pays dividends. Last time was Friday 31st of December 1993 where the investors holding the stock on Thursday 21st of October 1993 were paid $0.0397 per share. Over the last 2 times between 1990 and 1993, Prescient Therapeutics has paid $0.0714 with an average of $0.04 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Prescient Therapeutics 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $0.0490, you would have made a loss of $-0.0040 per share or -8.16%

No, the average daily trading liquidity for Prescient Therapeutics is $647 351 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Prescient Therapeutics has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Prescient Therapeutics to be medium [0.7 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.